about akston
process
pipeline
news
careers
contact
NEWS
23 February 2022
Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452
15 February 2022
Abstract P4-02-01: Targeting insulin receptor in estrogen receptor positive breast cancer
8 February 2022
Easier-To-Produce Room Temperature Covid Shot Shows Promise In Early Clinical Trials
8 February 2022
Akston Biosciences Announces Publication in Vaccine of Positive Data for a Room Temperature Protein Subunit COVID-19 Vaccine
6 January 2022
Akston Biosciences seeks USD 10m–25m raise, plans for further COVID-19 vaccine booster trials
21 December 2021
Akston Biosciences Announces Positive Top-Line Data from Phase II Study of COVID-19 Vaccine in the Netherlands
2 December 2021
What will tomorrow’s Covid-19 vaccines be like?
19 November 2021
Akston Biosciences Doses First Subjects in Phase II Clinical Trial in India of Second-Generation COVID-19 Vaccine
11 November 2021
‘Looking forward to second-gen vaccines,’ says WHO chief: From nasal sprays to multivariant jabs, vaccines in development spur hope of ending the pandemic
1 November 2021
Vaccinating the World: the effort to get COVID vaccines to everyone
1
5
6
7
11
